SAm级防撞活动护栏碰撞仿真分析

针对目前高速公路中央分隔带开口处活动护栏防撞等级较低的问题,提出了一种SAm级混凝土活动护栏及一种新型连接装置。基于有限元的方法,建立车辆与护栏的碰撞模型,通过LS-DYNA对车辆与护栏碰撞过程进行求解,根据不同车型的碰撞结果分别在缓冲,阻挡和导向性能上对护栏的安全性能进行评价,其中小型车辆与护栏碰撞后的OIV(Occupant Impact Velocity)值<12 m/s,ORA(Occupant Ridedown Acceleration)值<20 g且车辆没有驶出导向框;大型车辆与护栏碰撞后没有发生穿越、骑跨等现象且车辆没有驶出导向框,均满足护栏安全性能评价标准。     

利用SRTM数据修测高山区地貌的探讨

在高海拔区域测制地形图,如青藏高原地区,所获取的遥感影像局部存在着大范围的高山阴影或云雪覆盖,造成立体观测地貌困难的现象,探讨应用SRTM数据对这类特殊区域地貌进行修测补绘。介绍了数据处理的作业过程,并对实验区SRTM与SPOT5影像立体测图成果进行实验对比分析,成果符合要求。     

Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets

Introduction

Islets synthesise and secrete numerous peptides, some of which are known to be important regulators of islet function and glucose homeostasis. In this study, we quantified mRNAs encoding all peptide ligands of islet G protein-coupled receptors (GPCRs) in isolated human and mouse islets and carried out in vitro islet hormone secretion studies to provide functional confirmation for the species-specific role of peptide YY (PYY) in mouse islets.

Materials and methods

GPCR peptide ligand mRNAs in human and mouse islets were quantified by quantitative real-time PCR relative to the reference genes ACTB, GAPDH, PPIA, TBP and TFRC. The pathways connecting GPCR peptide ligands with their receptors were identified by manual searches in the PubMed, IUPHAR and Ingenuity databases. Distribution of PYY protein in mouse and human islets was determined by immunohistochemistry. Insulin, glucagon and somatostatin secretion from islets was measured by radioimmunoassay.

Results

We have quantified GPCR peptide ligand mRNA expression in human and mouse islets and created specific signalomes mapping the pathways by which islet peptide ligands regulate human and mouse GPCR signalling. We also identified species-specific islet expression of several GPCR ligands. In particular, PYY mRNA levels were ~ 40,000-fold higher in mouse than human islets, suggesting a more important role of locally secreted Pyy in mouse islets. This was confirmed by IHC and functional experiments measuring insulin, glucagon and somatostatin secretion.

Discussion

The detailed human and mouse islet GPCR peptide ligand atlases will allow accurate translation of mouse islet functional studies for the identification of GPCR/peptide signalling pathways relevant for human physiology, which may lead to novel treatment modalities of diabetes and metabolic disease.

     

基于重抽样分布的一类模糊累积和控制图

过程变量在代表产品或服务过程信息时并非完美，而使用模糊数可能是另一较好途径。文章进一步完善模糊累积和控制图，其中使用中心和扩展具有重抽样分布的模糊随机变量，并给出模拟例证。     

The modernity of Dedekind’s anticipations contained in What are numbers and what are they good for?

Archive for History of Exact Sciences - We show that Dedekind, in his proof of the principle of definition by mathematical recursion, used implicitly both the concept of an inductive cone from an...     

The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier

G protein-coupled receptor (GPCR) signalling is mediated through transactivation-independent signalling pathways or the transactivation of protein tyrosine kinase receptors and the recently reported activation of the serine/threonine kinase receptors, most notably the transforming growth factor-β receptor family. Since the original observation of GPCR transactivation of protein tyrosine kinase receptors, there has been considerable work on the mechanism of transactivation and several pathways are prominent. These pathways include the “triple membrane bypass” pathway and the generation of reactive oxygen species. The recent recognition of GPCR transactivation of serine/threonine kinase receptors enormously broadens the GPCR signalling paradigm. It may be predicted that the transactivation of serine/threonine kinase receptors would have mechanistic similarities with transactivation of tyrosine kinase pathways; however, initial studies suggest that these two transactivation pathways are mechanistically distinct. Important questions are the relative importance of tyrosine and serine/threonine transactivation pathways, the contribution of transactivation to overall GPCR signalling, mechanisms of transactivation and the range of cell types in which this phenomenon occurs. The ultimate significance of transactivation-dependent signalling remains to be defined but it appears to be prominent and if so will represent a new cell signalling frontier.